Panel discussion


Date:April 22, 2024

Panel title

How regulators can best support innovation

Panel summary

Regulatory agencies play a pivotal role in supporting Biotech R&D SMEs in their preparation of clinical trials and effective delivery of innovative and reliable therapies to patients. Engaging early with Biotech R&Ds increases the chances of complying with regulatory requirements. Experiences and available tools are discussed.

Speaker information


Monika Jones


Dr. Philippe Girard, Vice Director, Head of Medicinal product licences and surveillance, SWISSMEDIC Swiss Agency for Therapeutic Products
Daniel Meirelles Fernandes Pereira, Director, Member of the Board of Directors, ANVISA Brazilian Health Regulatory Agency
Bettina Ernst, CEO, Bernina Bioinvest & Innosuisse Innovation Council
Ulf Grawunder, PhD, Managing Partner, Viopas Venture Consulting, Basel, Switzerland; CEO, T-CURX, Würzburg, Germany

Company profile

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products.